HIVE vs PWP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

HIVE

59.7
AI Score
VS
HIVE Wins

PWP

53.8
AI Score

Investment Advisor Scores

HIVE

60score
Recommendation
HOLD

PWP

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIVE PWP Winner
Revenue 556.82M 164.00M PWP
Net Income 24.35M -221.61M PWP
Net Margin 4.4% -135.1% PWP
ROE 38.0% -60.8% PWP
ROA 2.9% -25.8% PWP
Total Assets 829.81M 857.69M HIVE
Cash 149.88M 138.99M PWP

Relative Price Performance (Last 90 Days)

HIVE 1M: -26.2% · 3M: -32.2% PWP 1M: -13.9% · 3M: -22.9%

Current Technical Phase

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.6%), weak momentum, RSI 36

RSI (14): 35.9 · Price: $1.75

PWP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $13.87

Fundamentals Snapshot

Metric HIVE PWP
Market Cap — —
Forward P/E -3.4 9.2
Trailing P/E — 35.5
Revenue (TTM) — —
Revenue Growth 0.7% 0.5%
Gross Margin 0.4% 1.0%
Operating Margin -0.6% 0.2%
EPS -1.53 0.39
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.